Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitius Res Regulatory News (CRES)

  • This share is currently suspended. It was suspended at a price of 3.00

Share Price Information for Citius Res (CRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.00
CRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

10 Nov 2023 10:00

RNS Number : 0934T
Citius Resources PLC
10 November 2023

Date: 10 November 2023

Citius Resources Plc

("Citius" or the "company")

Interim Financial Statements

for the six month period ended 31 October 2023

The Company is pleased to announce its Interim Results for the six-month period to 31 October 2023.

For further information please contact

Citius Resources Plc

Cameron Pearce (Director)

www.Citiusresources.co.uk

Tel: +44 (0)1624 681 250

info@citiusresources.co.uk

Tavira Securities Limited

Jonathan Evans

Tel: +44(0)20 7330 1833

Jonathan.evans@tavirasecurities.com

Shard Capital Partners

Damon Health

Tel: +44(0)20 7186 9927

Damon.heath@shardcapital.com

Interim Management Report

Dear shareholder,

I am pleased to present the interim report and accounts for the six-month period to 31 October 2023 for Citius Resources Plc.

The Company was pleased to announce during the period that we have entered into a binding Heads of Terms for the acquisition of 100% of the issued shares in Harena Resources Pty Ltd ("Harena") the 75% owner of the Ampasindava Rare Earths Project in Madagascar (the, "Acquisition"). Harena is an Australian domiciled company preparing to develop the 75% owned Ampasindava Rare Earths Project, which will include the mining and processing of Ionic Clay material to extract Rare Earth elements to produce Mixed Rare Earth Carbonate or Mixed Rare Earth Concentrate.

Harena is what can be described as Reverse Take Over ("RTO") advanced stages therefore the Company is well positioned to complete the Acquisition in this next reporting period which would constitute a RTO under the Listing Rules and accordingly, the company would apply for re-admission of its shares to the Official List and Main Market of the London Stock Exchange.

I would like to thank the board and our advisors for their dedication and professionalism in what can only be described as challenging market conditions and we look forward to applying for re-admission and moving the exciting Ampasindava Rare Earths project forward.

Cameron PearceChief Executive Officer

Responsibility Statement of the Directors' in respect of the Interim Report

The Directors are responsible for preparing the Interim Financial Statements in accordance with applicable law and regulations. In addition, the Directors have elected to prepare the Interim Financial Statements in accordance with International Financial Reporting Standards ("IFRSs"), as adopted by the United Kingdom ("UK").

The Interim Financial Statements are required to give a true and fair view of the state of affairs of the Group and of the profit or loss of the Group for that period.

In preparing these Interim Financial Statements, the Directors are required to:

· select suitable accounting policies and then apply them consistently;

· present information and make judgements that are reasonable, prudent and provides relevant, comparable and understandable information;

· provide additional disclosures when compliance with the specific requirements in IFRS is insufficient to enable users to understand the impact of particular transactions, other events and conditions on the entity's financial position and financial performance; and

· make an assessment of the Group's ability to continue as a going concern.

The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Group's transactions and disclose with reasonable accuracy at any time its financial position of the Group to enable them to ensure that the financial statements comply with the requirements of the Companies Act 2006. They have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Group and to prevent and detect fraud and other irregularities.

The Directors are responsible for the maintenance and integrity of the corporate and Interim Financial Statements. Legislation governing the preparation and dissemination of Interim Financial Statements may differ from one jurisdiction to another.

We confirm that to the best of our knowledge:

· the Interim Financial Statements, prepared in accordance with International Financial Reporting Standards as adopted by the UK, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group for the period;

· the Director's report includes a fair review of the development and performance of the business and the position of the group, together with a description of the principal risks and uncertainties that they face; and

· the annual report and financial statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for shareholders to assess the group's performance, business model and strategy.

Statement of Comprehensive Income for the year end ended 31 October 2023

6 months ended 31 October 2023

6 months ended 31 October 2022

12 months ended

30 April 2023

(Unaudited)

(Unaudited)

(Audited)

Notes

GBP

GBP

GBP

Administrative fees and other expenses

5

(340,378)

(139,526)

(444,287)

Operating loss

(340,378)

(136,526)

(444,287)

Finance costs

-

-

-

Loss before tax

(340,378)

(136,526)

(444,287)

Income tax

-

-

-

Total comprehensive loss for the period

(340,378)

(136,526)

(444,287)

Basic and diluted loss per share (pence)

7

(0.79)

(0.44)

(1.03)

There was no other comprehensive income for the period ended on 31 October 2023.

Statement of Financial Position as at 31 October 2023

Note

As at

31 October 2023

As at

31 October 2022

As at

30 April

2023

(Unaudited)

(Unaudited)

(Audited)

GBP

GBP

GBP

Current assets

Cash and cash equivalents

61,297

345,886

249,341

Other receivables

11,570

314,411

154,759

Total current assets

72,867

660,297

412,100

Current liabilities

Creditors: Amounts falling due within one year

120,728

62,660

119,223

Total current liabilities

120,728

62,660

119,223

Net (liabilities)/assets

(47,861)

597,637

292,877

Equity

Share capital

8

216,250

216,250

216,250

Share premium

8

921,797

921,797

921,797

Warrant reserves

17,422

17,422

17,422

Retained earnings

(1,203,330)

(557,832)

(862,592)

Total equity

(47,861)

597,637

292,877

Statement of Changes in Equity for the six month period ended 31 October 2023

Share

capital

Share premium

Warrants reserves

Retained earnings

Total equity

GBP

GBP

GBP

GBP

GBP

Balance as at 30 April 2022

216,250

921,797

17,422

(418,306)

737,163

Loss for the period

-

-

-

(139,526)

(139,526)

Total comprehensive loss

-

-

-

(139,526)

(139,526)

Balance as at 31 October 2022

216,250

921,797

17,422

(557,832)

597,637

Loss for the period

-

-

-

(304,760)

(304,760)

Total comprehensive loss

-

-

-

(304,760)

(304,760)

Balance as at 30 April 2023

216,250

921,797

17,422

(862,592)

(292,877)

Loss for the period

-

-

-

(340,738)

(340,738)

Total comprehensive loss

-

-

-

(340,738)

(340,738)

Balance as at 31 October 2023

216,250

921,797

17,422

(1,203,330)

(47,861)

Statement of Cash Flows for the six month period ended 31 October 2023

Notes

As at 31 October 2023

As at 31 October 2022

As at 30

April 2023

(Unaudited)

(Unaudited)

(Audited)

GBP

GBP

GBP

Operating activities

Loss after tax

(340,737)

(139,526)

(444,287)

Changes in working capital

(Decrease)/increase in trade and other receivables

(3,570)

(294,336)

12,076

Increase in trade and other payables

1,505

22,645

79,208

Net cash flows utilised by operating activities

(342,802)

(411,217)

(353,003)

Investing activities

Decrease/(increase) Loan to Kamalenge Gold Project

249,341

-

(249,341)

Net cash flows from investment activities

249,341

-

(249,341)

Increase in cash and cash equivalents

(93,461)

(411,217)

(602,344)

Cash and short-term deposits brought forward

154,759

757,103

757,103

Cash and cash equivalent at

31 October

61,298

345,886

154,759

Notes to the Financial Statements for the six month period ended 31 October 2023

1. General

Citius Resources Plc (the "Company") is a public limited company incorporated and registered in England and Wales on 15 April 2020 with registered company number 12557958. Its registered address 167-169 Great Portland Street, Fifth Floor, London, W1W 5PF.

The Company did not trade during the period under review.

2. Accounting Policies

Basis of preparation

The interim financial statements of Citius Resources Plc are unaudited condensed financial statements for the 6 month period ended 31 October 2023.

The accounting policies applied by the Company in these Interim Financial Statements, are the same as those applied by the Company in its financial statements and have been prepared on the basis of the accounting policies applied for the financial year to 30 April 2023 which have been prepared in accordance with IFRS as adopted by UK. The Company Interim Financial Statements have been prepared using the measurement basis specified by IFRS each type of asset, liability, income and expense.

The Company Interim Financial Statements are presented in GBP, which is the Company's functional currency. All amounts have been rounded to the nearest pound, unless otherwise stated.

3. Critical accounting estimates and judgments

In preparing the Company's Interim Financial Statements, the Directors have to make judgments on how to apply the Company's accounting policies and make estimates about the future. The Directors do not consider there to be any critical judgments that have been made in arriving at the amounts recognised in the Company Interim Financial Statements.

4. Significant accounting policies

The accounting policies adopted are consistent with those followed in the preparation of the annual financial statements of Citius Resources Plc, for the year ended 30 April 2023. A copy of these financial statements is available on the Company website at https://citiusresources.co.uk/

5. Administrative fee and other expenses

6 months ended 31 October 2023

6 months ended 31 October 2022

12 months ended

30 April 2023

GBP

GBP

GBP

Directors' remuneration

24,000

24,000

48,000

Professional fees

24,455

90,524

115,785

Project cost expenditure

272,081

-

216,112

Audit fees

10,266

15,000

36,000

Administration fees

9,000

9,000

18,000

Miscellaneous fees

936

1,002

10,390

Total

340,738

139,526

444,287

The company did not employ any staff during the period other than Directors. The Directors are the only members of key management and their remuneration related solely to short term employee benefits.

6. Impairment of the loan

On 9 June 2022 the Company announced that it has entered into a binding Heads of Terms with regard to the possible acquisition of 100% of the share capital of AUC Mining (U) Limited ("AUC"). As part of the Heads of Terms, the Company loaned AUC £249,341. On 26 October 2023, the Company agreed to terminate the agreement with AUC for the acquisition of the Kamalenge project, and therefore, the loan was impaired to Nil.

7. Basic and diluted loss per share

The calculation of the basic and diluted loss per share is based on the following data:

6 months ended 31 October 2023

6 months ended 31 October 2022

12 months ended 30 April 2022

Earnings

Loss for the period (GBP)

(340,738)

(139,526)

(444,287)

Number of shares

Weighted average number of Shares

43,250,000

31,692,482

43,250,000

Basic and diluted loss per share (pence)

(0.79)

(0.44)

(1.03)

There are no potentially dilutive shares in issue.

8. Share capital issued

Number of shares issued

Nominal value per share

Share capital

Share premium

Total share capital

GBP

GBP

GBP

GBP

At 30 October 2022

43,250,000

0.005

216,250

921,797

1,138,047

At 31 April 2023

43,250,000

0.005

216,250

921,797

1,138,047

At 31 October 2023

43,250,000

0.005

216,250

921,797

1,138,047

9. Related party transactions

The are no related party transactions during the period except for the Directors' remuneration, which has been disclosed in note 5.

10. Events after the reporting date

There are no events after the reporting date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IR GCBDBSUBDGXG
12
Date   Source Headline
1st Dec 20239:01 amRNSLodgement of Prospectus
10th Nov 202310:00 amRNSHalf-year Report
26th Oct 20239:07 amRNSProject Update
15th Sep 202310:30 amRNSResult of AGM
22nd Aug 20233:07 pmRNSAnnual Results 30 April 2023 & Notice of AGM
29th Nov 202210:31 amRNSHalf-year Report
28th Sep 20223:08 pmRNSChange of Registered Office
19th Aug 202210:09 amRNSResult of AGM
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
9th Jun 20227:40 amRNSStatement re. Suspension
9th Jun 20227:30 amRNSSuspension - Citius Resources Plc
7th Apr 202210:43 amRNSAppointment of Joint Broker
25th Jan 20227:02 amRNSChange of Adviser
1st Dec 20217:00 amRNSInterim Financial Statements
29th Oct 202110:12 amRNSResult of AGM
1st Oct 20213:52 pmRNSNotice of AGM
25th Aug 20217:00 amRNSAdmission and First Day of Dealings
1st Oct 20087:00 amRNSSuspension - Crescent Hydropolis Resorts Plc
30th Sep 20089:56 amRNSInterim Results
1st Sep 20087:00 amRNSNotice of Resignation of Nomi
29th Aug 20081:00 pmRNSRestoration - Crescent Hydrop
29th Aug 20081:00 pmRNSFinal Results
25th Jun 20081:30 pmRNSSuspension Statement
25th Jun 20081:30 pmRNSSuspension - Crescent Hydropo
21st Apr 20085:19 pmRNSCorrection: Board Changes
11th Apr 20089:52 amRNSIssue of Equity Pending
28th Mar 20083:26 pmRNSTotal Voting Rights
26th Mar 20083:21 pmRNSIssue of Equity
18th Mar 200812:35 pmRNSDirectorate Changes
18th Dec 20074:49 pmRNSAGM Statement
16th Nov 200711:29 amRNSAGM Statement
5th Oct 200712:29 pmRNSInterim Results
28th Sep 20077:00 amRNSInterim Results
28th Aug 20079:26 amRNSMiddle East Projects Update
20th Aug 200711:59 amRNSAIM Rule 26
29th Jun 20077:00 amRNSFinal Results
18th Apr 20076:27 pmRNSDirectorate Change
6th Mar 20071:11 pmRNSChange of Registered Office
28th Feb 20077:00 amRNSTotal Voting Rights
27th Feb 20073:38 pmRNSMemorandum of Understanding
5th Feb 20077:01 amRNSIssue of Equity
22nd Dec 200612:07 pmRNSTotal Voting Rights
7th Dec 20061:38 pmRNSIssue of Equity
4th Dec 200611:37 amRNSHolding(s) in Company
28th Nov 20063:11 pmRNSHolding(s) in Company
26th Oct 20062:42 pmRNSHolding(s) in Company
24th Oct 20063:17 pmRNSIssue of Equity
29th Sep 200612:48 pmRNSInterim Results
26th Sep 200611:12 amRNSDirector/PDMR Shareholding
11th Sep 20063:34 pmRNSDirectorate Change
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.